Improving the Antitumor Activity of R-CHOP With NGR-hTNF in Primary CNS Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Improving the Antitumor Activity of R-CHOP With NGR-hTNF in Primary CNS Lymphoma: Final Results of a Phase 2 Trial
Blood Adv 2020 Aug 11;4(15)3648-3658, AJM Ferreri, T Calimeri, M Ponzoni, F Curnis, GM Conte, E Scarano, E Rrapaj, D De Lorenzo, D Cattaneo, F Fallanca, A Nonis, M Foppoli, P Lopedote, G Citterio, LS Politi, M Sassone, P Angelillo, E Guggiari, S Steffanoni, V Tarantino, F Ciceri, C Bordignon, N Anzalone, A CortiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.